| Authors: |
Hachizovu S; National Health Research and Training Institute, Lusaka, Zambia. sebastianhachizovu4@gmail.com.; Global Health Institute, University of Antwerp, Antwerp, Belgium. sebastianhachizovu4@gmail.com., Manyando C; National Health Research and Training Institute, Lusaka, Zambia., Nambozi M; National Health Research and Training Institute, Lusaka, Zambia., Khondowe S; National Health Research and Training Institute, Lusaka, Zambia., Hamainza B; Programme Coordination Unit, Ministry of Health, Lusaka, Zambia., Mukumbuta D; National Malaria Elimination Centre, Ministry of Health, Lusaka, Zambia., Rietveld H; MMV Medicines for Malaria Venture, Geneva, Switzerland., Mukomena Sompwe E; National Malaria Control Programme, Ministry of Health, Kinshasa, Democratic Republic of Congo.; University of Lubumbashi, Lubumbashi, Democratic Republic of Congo., Kikunda G; National Malaria Control Programme, Lubumbashi, Haut-Katanga Province, Democratic Republic of Congo., Muhindo-Mavoko H; University of Kinshasa, Kinshasa, Democratic Republic of Congo., Luzolo Khote F; Global Health Institute, University of Antwerp, Antwerp, Belgium.; University of Kinshasa, Kinshasa, Democratic Republic of Congo., Kanyamukenge D; Global Health Institute, University of Antwerp, Antwerp, Belgium.; University of Lubumbashi, Lubumbashi, Democratic Republic of Congo., Bastiaens H; Global Health Institute, University of Antwerp, Antwerp, Belgium., Kakudji A; University of Lubumbashi, Lubumbashi, Democratic Republic of Congo., Maseko T; Global Health Institute, University of Antwerp, Antwerp, Belgium., Makenga G; Global Health Institute, University of Antwerp, Antwerp, Belgium.; National Institute for Medical Research, Tanga, Tanzania., Baraka V; National Institute for Medical Research, Tanga, Tanzania., Mutombo A; University of Lubumbashi, Lubumbashi, Democratic Republic of Congo., Duparc S; MMV Medicines for Malaria Venture, Geneva, Switzerland., Van Geertruyden JP; Global Health Institute, University of Antwerp, Antwerp, Belgium. |
